Why the study?
Do therapeutic interventions proven in the general population reduce cardiovascular morbidity and mortality in patients with end-stage renal disease?
Population
Patients with end-stage renal disease (ESRD) on dialysis and pre-dialysis chronic kidney disease (CKD)
Comparison
Various therapeutic interventions including… vs Standard therapy or placebo
Design
Review
Authors
Loading...
General CV interventions lack proven benefit in ESRD; leaves open the need for disease-specific trials.
Do therapeutic interventions proven in the general population reduce cardiovascular morbidity and mortality in patients with end-stage renal disease?
This review highlights the consistent failure of traditional cardiovascular risk reduction strategies (like statins and intensive dialysis) to improve survival in ESRD patients, emphasizing the need for disease-specific trials.
Covic et al. (2007) studied this question.